Comparative irritancy of oxaprozin on the gastrointestinal tract of rats and mice: relationship to drug uptake and effects in vivo on eicosanoid metabolism-Reference-Cited by-同舟云学术

Comparative irritancy of oxaprozin on the gastrointestinal tract of rats and mice: relationship to drug uptake and effects in vivo on eicosanoid metabolism

Published:2007-03-31 Issue:5 Volume:2 Page:439-450
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

RAINSFORD K. D.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1988.tb00717.x/fullpdf

Reference16 articles.

1. Comparison of the gastric ulcerogenic activity of new non-steroid anti-inflammatory drugs in stressed rats;Rainsford;Br J Pharmacol,1981

2. A profile of the rat gastrointestinal toxicity of aspirin, indomethacin, oxaprozin, phenylbutazone and fentiazic in arthritic and normal Lewis rats;Shriver;Toxicol Appl Pharmacol,1975

3. Gastrointestinal blood loss of oxaprozin and aspirin with placebo control;Lussier;J Clin Pharmacol,1982

4. Gastroscopic evaluation of the effect of aspirin and oxaprozin on the gastric mucosa;Lanza;J Clin Pharmacol,1981

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticonvulsant activity of oxaprozin in a rat model of pentylenetetrazole-induced seizure by targeting oxidative stress and SIRT1/PGC1α signaling;Canadian Journal of Physiology and Pharmacology;2022-06-01

2. Nonsteroidal Anti-inflammatory Drug Oxaprozin is Beneficial Against Seizure-induced Memory Impairment in an Experimental Model of Seizures in Rats: Impact On Oxidative Stress and Nrf2/HO-1 Signaling Pathway;Journal of Molecular Neuroscience;2022-01-27

3. Gastrointestinal Adverse Reactions from Ibuprofen;Ibuprofen;2015-07-03

4. A review of the emerging profile of the anti-inflammatory drug oxaprozin;Expert Opinion on Pharmacotherapy;2005-05

5. Recent pharmacodynamic and pharmacokinetic findings on oxaprozin;InflammoPharmacology;2002-08